These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 23199483

  • 21. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5892-6. PubMed ID: 21852133
    [Abstract] [Full Text] [Related]

  • 22. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT.
    J Med Chem; 2011 Dec 22; 54(24):8271-7. PubMed ID: 22077347
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B, Ceruso M, Carta F, Supuran CT.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5883-90. PubMed ID: 25267005
    [Abstract] [Full Text] [Related]

  • 24. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö, Akdemir A, Karalı N, Supuran CT.
    Org Biomol Chem; 2015 Jun 21; 13(23):6493-9. PubMed ID: 25967275
    [Abstract] [Full Text] [Related]

  • 25. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 26. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O, Biswas S, Lastra K, McKenna R, Supuran CT.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6674-80. PubMed ID: 24012377
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA, Boone CD, Rife BD, Supuran CT, McKenna R.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7210-5. PubMed ID: 24090602
    [Abstract] [Full Text] [Related]

  • 32. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
    Winum JY, Vullo D, Casini A, Montero JL, Scozzafava A, Supuran CT.
    J Med Chem; 2003 Dec 04; 46(25):5471-7. PubMed ID: 14640555
    [Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY, Cecchi A, Montero JL, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jul 01; 15(13):3302-6. PubMed ID: 15908201
    [Abstract] [Full Text] [Related]

  • 34. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides.
    Métayer B, Mingot A, Vullo D, Supuran CT, Thibaudeau S.
    Chem Commun (Camb); 2013 Jul 11; 49(54):6015-7. PubMed ID: 23503420
    [Abstract] [Full Text] [Related]

  • 35. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII.
    Tarko L, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1404-9. PubMed ID: 23206986
    [Abstract] [Full Text] [Related]

  • 36. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö, Akdemir A, Isik S, Vullo D, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1386-91. PubMed ID: 23352754
    [Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
    Winum JY, Innocenti A, Scozzafava A, Montero JL, Supuran CT.
    Bioorg Med Chem; 2009 May 15; 17(10):3649-52. PubMed ID: 19375921
    [Abstract] [Full Text] [Related]

  • 38. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC, Chiche J, Grellier C, Lopez M, Bornaghi LF, Maresca A, Supuran CT, Pouysségur J, Poulsen SA.
    J Med Chem; 2011 Oct 13; 54(19):6905-18. PubMed ID: 21851094
    [Abstract] [Full Text] [Related]

  • 39. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E, Carotti A, Ceruso M, Supuran CT, Gioiello A.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3422-5. PubMed ID: 24948563
    [Abstract] [Full Text] [Related]

  • 40. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Rami M, Maresca A, Smaine FZ, Montero JL, Scozzafava A, Winum JY, Supuran CT.
    Bioorg Med Chem Lett; 2011 May 15; 21(10):2975-9. PubMed ID: 21470859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.